1037 related articles for article (PubMed ID: 24492985)
21. Efficacy and safety of triple antihypertensive therapy with the olmesartan/amlodipine/hydrochlorothiazide combination.
Volpe M; Christian Rump L; Ammentorp B; Laeis P
Clin Drug Investig; 2012 Oct; 32(10):649-64. PubMed ID: 22909147
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of an amlodipine/olmesartan treatment algorithm in patients with or without type 2 diabetes and hypertension (a secondary analysis of the BP-CRUSH study).
Nesbitt SD; Shojaee A; Maa JF; Weir MR
J Hum Hypertens; 2013 Jul; 27(7):445-52. PubMed ID: 23254596
[TBL] [Abstract][Full Text] [Related]
23. Triple-combination treatment with olmesartan medoxomil/amlodipine/ hydrochlorothiazide in Hispanic/Latino patients with hypertension: the TRINITY study.
Lewin AJ; Kereiakes DJ; Chrysant SG; Izzo JL; Oparil S; Lee J; Fernandez V; Melino M
Ethn Dis; 2014; 24(1):41-7. PubMed ID: 24620447
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial.
Sohn IS; Kim CJ; Oh BH; Hong TJ; Park CG; Kim BS; Chung WB;
Am J Cardiovasc Drugs; 2016 Apr; 16(2):129-38. PubMed ID: 26691333
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and tolerability of fixed-dose amlodipine/olmesartan medoxomil with or without hydrochlorothiazide in Hispanic and non-Hispanic patients whose blood pressure is uncontrolled on antihypertensive monotherapy.
Punzi H; Shojaee A; Maa JF;
Ther Adv Cardiovasc Dis; 2012 Aug; 6(4):149-61. PubMed ID: 22855062
[TBL] [Abstract][Full Text] [Related]
26. Olmesartan/amlodipine/hydrochlorothiazide in participants with hypertension and diabetes, chronic kidney disease, or chronic cardiovascular disease: a subanalysis of the multicenter, randomized, double-blind, parallel-group TRINITY study.
Kereiakes DJ; Chrysant SG; Izzo JL; Littlejohn T; Melino M; Lee J; Fernandez V; Heyrman R
Cardiovasc Diabetol; 2012 Oct; 11():134. PubMed ID: 23110471
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of a stepped-care regimen using olmesartan medoxomil, amlodipine and hydrochlorothiazide in patients with moderate-to-severe hypertension: an open-label, long-term study.
Volpe M; Miele C; Haag U
Clin Drug Investig; 2009; 29(6):381-91. PubMed ID: 19432498
[TBL] [Abstract][Full Text] [Related]
28. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
Lacourcière Y; Wright JT; Samuel R; Zappe D; Purkayastha D; Black HR;
Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192
[TBL] [Abstract][Full Text] [Related]
29. Real-life effectiveness, safety, and tolerability of amlodipine/valsartan or amlodipine/valsartan/hydrochlorothiazide single-pill combination in patients with hypertension from Pakistan.
Khan W; Moin N; Iktidar S; Sakrani J; Abid R; Afzal J; Maheshwary N; Kumar K; Siddiqi A; Qadir M
Ther Adv Cardiovasc Dis; 2014 Apr; 8(2):45-55. PubMed ID: 24562476
[TBL] [Abstract][Full Text] [Related]
30. Amlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: Secondary analyses evaluating efficacy and safety.
Calhoun DA; Crikelair NA; Yen J; Glazer RD
Adv Ther; 2009 Nov; 26(11):1012-23. PubMed ID: 20024680
[TBL] [Abstract][Full Text] [Related]
31. Effects of high dose olmesartan medoxomil plus hydrochlorothiazide on blood pressure control in patients with grade 2 and grade 3 hypertension.
Rump LC; Girerd X; Sellin L; Stegbauer J
J Hum Hypertens; 2011 Sep; 25(9):565-74. PubMed ID: 21107435
[TBL] [Abstract][Full Text] [Related]
32. Long-term efficacy of a combination of amlodipine and olmesartan medoxomil ± hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial.
Oparil S; Chrysant SG; Melino M; Lee J; Karki S; Heyrman R
J Hum Hypertens; 2010 Dec; 24(12):831-8. PubMed ID: 20200547
[TBL] [Abstract][Full Text] [Related]
33. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
Shimada K; Ogihara T; Saruta T; Kuramoto K;
Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
[TBL] [Abstract][Full Text] [Related]
34. A randomized, double-blind, forced-titration study to compare olmesartan medoxomil versus losartan potassium in patients with stage 1 and 2 hypertension.
Weir MR; Punzi HA; Flack JM; Stoakes KA; Chavanu KJ; Li W; Dubiel R
Postgrad Med; 2011 Jan; 123(1):80-7. PubMed ID: 21293087
[TBL] [Abstract][Full Text] [Related]
35. Systolic blood pressure reduction with olmesartan medoxomil versus nitrendipine in elderly patients with isolated systolic hypertension.
Mallion JM; Heagerty A; Laeis P
J Hypertens; 2007 Oct; 25(10):2168-77. PubMed ID: 17885562
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and tolerability of olmesartan medoxomil combined with amlodipine in patients with moderate to severe hypertension after amlodipine monotherapy: a randomized, double-blind, parallel-group, multicentre study.
Volpe M; Brommer P; Haag U; Miele C
Clin Drug Investig; 2009; 29(1):11-25. PubMed ID: 19067471
[TBL] [Abstract][Full Text] [Related]
37. Effects of an olmesartan medoxomil based treatment algorithm on 24-hour blood pressure control in patients with hypertension and type 2 diabetes.
Neutel JM; Kereiakes DJ; Waverczak WF; Stoakes KA; Xu J; Shojaee A
Curr Med Res Opin; 2010 Mar; 26(3):721-8. PubMed ID: 20085534
[TBL] [Abstract][Full Text] [Related]
38. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
[TBL] [Abstract][Full Text] [Related]
39. Olmesartan medoxomil combined with hydrochlorothiazide improves 24-hour blood pressure control in moderate-to-severe hypertension.
Rosenbaum D; Girerd X
Curr Med Res Opin; 2012 Feb; 28(2):179-86. PubMed ID: 22114906
[TBL] [Abstract][Full Text] [Related]
40. Use of 24-h ambulatory blood pressure monitoring to assess blood pressure control: a comparison of olmesartan medoxomil and amlodipine besylate.
Chrysant SG; Marbury TC; Silfani TN
Blood Press Monit; 2006 Jun; 11(3):135-41. PubMed ID: 16702822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]